Zoetis Financial Diagnostics

ZTS -- USA Stock  

USD 121.02  1.38  1.15%

The current investor indifference towards the small price fluctuations of Zoetis may raise some interest from investors as it closed today at a share price of 120.24 on 3116126.000 in trading volume. The company directors and management did not add any value to Zoetis investors in August. However, most investors can still diversify their portfolios with Zoetis to hedge your portfolio against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.5054. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. This diagnostics interface makes it easy to digest most current publicly released information about Zoetis as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Zoetis price relationship with some important fundamental indicators such as market cap and management efficiency. See also Your Current Watchlist.

Zoetis Note

About 95.0% of the company outstanding shares are owned by institutional investors. The company last dividend was issued on 2019-07-18. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people. For more information please call Juan Alaix at 973-822-7000 or visit http://www.zoetis.com.

Zoetis Alerts

Zoetis has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
Over 95.0% of the company outstanding shares are owned by institutional investors
Latest headline from altcoinmercury.com: Zoetis INC Cl A Market Valuation Rose While Boston Advisors LLC Has Decreased Its Stake - The Altcoin Mercury

Zoetis Upcoming Events

Upcoming Quarterly ReportAugust 1, 2019
Next Earnings ReportNovember 7, 2019

Zoetis Earning Estimates

EPSEstimate Date
Quarterly Estimate0.82August 1, 2019
Zoetis normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Zoetis SEC Filings

Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Regulation FD Disclosure
Unclassified Corporate Event
Unclassified Corporate Event
Unclassified Corporate Event
Financial Statements and Exhibits. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Termination of a Material Definitive Agreement. Entry into a Material Definitive Agreement
Financial Statements and Exhibits. Regulation FD Disclosure
Financial Statements and Exhibits. Results of Operations and Financial Condition

Zoetis Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare

Market Capitalization

The company currently falls under 'Large-Cap' category with total capitalization of 57.14B.

Profitablity

The company has Net Profit Margin of 22.74 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 38.49 % which entails that for every 100 dollars of revenue it generated 0.38 of operating income.

Management Efficiency

Zoetis has Return on Asset of 12.56 % which means that on every $100 spent on asset it made $12.56 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 62.6 % implying that it generated $62.6 on every 100 dollars invested.

Stock Holders for Zoetis

Information
Ratio
Value
At Risk
NYSE 0.0127 (1.27) 
Nasdaq US Large Cap Growth Inde 0.00  0.00 
NASDAQ N America Large Mid Cap(0.0099) (2.22) 
NYSE ARCA PHARMACEUTICAL INDEX(0.07) (1.77) 
SPDR SP Pharmaceuticals ETF(0.05) (2.13) 
AB Cap Fund Inc AB Concentr 0.0105 (1.46) 
AB Cap Fund Inc AB Concentr 0.0279 (1.46) 
AB Cap Fund Inc AB Concentr 0.0283 (1.46) 
Ivy Mid Cap Growth Fund Class Y 0.0293 (1.61) 
Ivy Mid Cap Growth Fund Class R 0.0276 (1.59) 
Ivy Mid Cap Growth Fund Class C 0.0264 (1.63) 
Ivy Mid Cap Growth Fund Class A 0.0287 (1.61) 
VanEck Vectors Agribusiness ETF 0.0032 (2.53) 
Victory Munder Mid Cap Core Gro 0.0045 (1.90) 
ClearBridge Large Cap Growth Fu 0.0327 (1.29) 
JPMorgan Diversified Return U S 0.0338 (1.28) 
Ivy Mid Cap Growth Fund Class I 0.037 (1.61) 
Pinnacle TrendRating Innovative(0.0379) (2.25) 
Ivy Mid Cap Growth Fund Class E 0.0203 (1.62) 
Realty Shares DIVCON Dividend G 0.0366 (1.76) 

Technical Drivers

As of 17 of September Zoetis maintains Market Risk Adjusted Performance of (0.54), Downside Deviation of 1.37 and Mean Deviation of 0.8679. Relative to Fundamental Indicators, Macroaxis technical analysis interface lets you check existing technical drivers of Zoetis as well as the relationship between them. Specifically you can use this information to find out if the organization will indeed mirror its model of past data patterns or the prices will eventually revert. We found nineteen technical drivers for Zoetis which can be compared to its rivals. Please check out Zoetis Treynor Ratio, and the relationship between Variance and Potential Upside to decide if Zoetis is priced fairly providing market reflects its latest price of 121.02 per share. Given that Zoetis has Jensen Alpha of 0.1062, we strongly advise you confirm Zoetis prevalent market performance to make sure the company can sustain itself at future point.

Zoetis Price Movement Analysis

The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of Zoetis for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Zoetis short-term fluctuations and highlight longer-term trends or cycles. View also all equity analysis or get more info about simple moving average overlap studies indicator.

Zoetis Insider Trading Activities

Zoetis Outstanding Bonds

MaturityCouponRating
98978VAB9 3.25%02/01/20233.25
BBB-
98978VAE3 1.15%02/01/20161.15
BBB-
98978VAG8 1.875%02/01/20181.875
BBB-
98978VAH6 4.7%02/01/20434.7
BBB-

Zoetis Technical and Predictive Indicators

Zoetis Forecast Models

Recommendations

Zoetis Analyst Recommendations

Target PriceAdvice# of Analysts
109.08Buy12Odds
Zoetis current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Zoetis Analyst Advice  

Vital Value Indicators

Zoetis Basic Pricing Drivers

Quick Ratio2.58
Fifty Two Week Low78.90
Trailing Annual Dividend Rate0.58
Revenue Growth9.30%
Payout Ratio20.49%
Shares Short Prior Month3.67M
Average Daily Volume Last 10 Day2.72M
Average Daily Volume In Three Month1.96M
Earnings Growth-2.50%
Shares Percent Shares Out0.91%
Gross Margins68.21%
Earnings Quarterly Growth-3.40%
Short Percent Of Float0.90%
Forward Price Earnings30.14
Float Shares477.12M
Fifty Two Week High130.08
Enterprise Value To Ebitda26.94
Fifty Day Average123.13
Two Hundred Day Average109.33
Trailing Annual Dividend Yield0.48%
Enterprise Value To Revenue10.37
See also Your Current Watchlist. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Search macroaxis.com